Malignant Mixed Mullerian Tumor
Symptoms, Doctors, Treatments, Advances & More

Malignant Mixed Mullerian Tumor Overview

Save information for later
Sign Up

Learn About Malignant Mixed Mullerian Tumor

What is the definition of Malignant Mixed Mullerian Tumor?
Malignant mixed Mullerian tumor (MMMT), also called a carcinosarcoma, is a type of cancer that contains two types of cancer cells - carcinoma and sarcoma cells. These tumors usually develop in tissues of the female genital tract. The majority of these tumors arise in the uterus, though they can also occur in the ovaries, fallopian tubes, and cervix. Very rarely, MMMTs can develop in the female peritoneum (lining of the abdominal wall).
What are the alternative names for Malignant Mixed Mullerian Tumor?
  • Malignant mixed Mullerian tumor
  • Carcinosarcoma
  • MMMT
  • Mixed Mullerian tumor
  • Mixed tumor, Mullerian
Who are the top Malignant Mixed Mullerian Tumor Local Doctors?
Distinguished in Malignant Mixed Mullerian Tumor
Dr. Wei-chien M. Lin
Oncology | Obstetrics and Gynecology
Distinguished in Malignant Mixed Mullerian Tumor
Dr. Wei-chien M. Lin
Oncology | Obstetrics and Gynecology
Referral may be required

Wei-Chien M. Lin, MD Private Practice

15031 Rinaldi St., Ste 150, 
Mission Hills, CA 
818-660-4700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wei-chien Lin is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Mission Hills, California. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Lin is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Lin is currently accepting new patients.

Distinguished in Malignant Mixed Mullerian Tumor
Distinguished in Malignant Mixed Mullerian Tumor
Referral may be required

Prisma Health Cancer Institute – Faris Rd.

900 West Faris Road, 
Greenville, SC 
864-679-3900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Larry Puls is an Oncologist practicing medicine in Greenville, South Carolina. Dr. Puls is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Puls is board certified in American Board Of Obstetrics And Gynecology. Dr. Puls is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Malignant Mixed Mullerian Tumor
Dr. Andrew Berchuck
Gynecologic Oncology
Distinguished in Malignant Mixed Mullerian Tumor
Dr. Andrew Berchuck
Gynecologic Oncology
Referral may be required

Duke Cancer Center Gynecology Clinic

20 Duke Medicine Cir, 
Durham, NC 
919-668-6688
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Berchuck is a Gynecologic Oncologist practicing medicine in Durham, North Carolina. Dr. Berchuck is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Tubal Ligation. Dr. Berchuck is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology. Dr. Berchuck is currently accepting new patients.

View All Doctors
What are the latest Malignant Mixed Mullerian Tumor Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center